|
"sievert w"的相關文件
顯示項目 11-14 / 14 (共2頁)
<< < 1 2
每頁顯示[10|25|50]項目
| 國立成功大學 |
2012-09 |
Entecavir efficacy and safety in patients >= 50 years of age
|
Sievert, W.; Wedemeyer, H.; Gish, R.; Nguyen, T.; Lai, C. L.; Llamoso, C.; Chang, T. T. |
| 國立成功大學 |
2009-10 |
3 years of ETV re-treatment in HBeAg (-) patients who previously discontinued ETV treatment: results from study ETV-901
|
Sievert, W.; Shouval, D.; Lai, C.; Chang, Ting-Tsung; Gadano, A.; Wu, S.; Halota, W.; Tsai, N. C.; Zhang, H.; Iloeje, U.; Munafo, L.; Newman, J.; Slade, P. |
| 國立成功大學 |
2007-11-15 |
Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B
|
Lim, S. G.; Marcellin, P.; Tassopoulos, N.; Hadziyannis, S.; Chang, Ting-Tsung; Tong, M.; Sievert, W.; Hu, P.; Arterburn, S.; Brosgart, C. L. |
| 國立成功大學 |
2002-10 |
48 weeks of adefovir dipivoxil (ADV) results in improvement in fibrosis and decreased progression of fibrosis in a double-blind, randomized, placebo-controlled study for the treatment of patients with HBeAg plus chronic hepatitis B.
|
Goodman, Zack; Marcellin, P; Chang, Ting-Tsung; Lim, Seng-Gee; Tong, Myron; Sievert, W; Shiffman, M; Jeffers, L; Wulfsohn, M; Fallis, R; Fry, J; Brosgart, C |
顯示項目 11-14 / 14 (共2頁)
<< < 1 2
每頁顯示[10|25|50]項目
|
